Financing channel feed – Endpoints News

Financing channel feed

Contineum says it will seek $136M in IPO to back its mid-stage neuro drug

Last year

Boundless starts IPO spring with $100M listing for cancer small molecules

Last year

Updated: Moderna partners with Blackstone on flu shots, nabbing up to $750M in R&D funding

Last year

Exclusive: Athena Countouriotis' Avenzo nabs $150M to in-license more assets

Last year

Why Lenz picked a reverse merger instead of an IPO: Q&A

Last year

Galderma targets one of this year's biggest European IPOs with top-of-the-range share price

Last year

Boundless Bio seeks $88M in IPO as it runs two Ph1 cancer trials

Last year

Former Prometheus execs raise $400M for precision immunology startup: 'The band is back together'

Last year

Exclusive: ‘If you could hallucinate a protein’: Profluent snags $35M for generative AI models

Last year

The megaround rebound: Private biotechs rack up $100M+ financings

Last year

Clasp Therapeutics emerges with $150M based on work from Bert Vogelstein, Drew Pardoll

Last year

'Cell therapy without cells': Capstan raises $175M to test in vivo CAR-T

Last year

Mid-stage neuroscience startup Engrail raises $157M

Last year

Contineum Therapeutics files for IPO with MS drug in PhII

Last year

Female investors track progress, call for more women on boards and in leadership roles

Last year

Pfizer-backed UK biotech raises £25M to advance mitophagy pipeline

Last year

German ADC biotech Tubulis raises $138M to enter the clinic and expand in US

Last year

Swedish biotech raises €30M Series A to develop off-the-shelf gene therapy for solid tumors

Last year

Exclusive: ‘ChatGPT for DNA’: Relation nabs $35M, with Nvidia backing, for osteoporosis work

Last year

FOMO, detox and depth: Why this biotech rally may (finally) be real

Last year

Early-stage oncology startup Boundless Bio files for IPO

Last year

As the biotech markets warm up, signs point to crossover rounds returning

Last year

Alumis closes a $259M Series C to back its TYK2, flirts with talk about an IPO

Last year

Sionna raises $182M for cystic fibrosis drugs different from Vertex's approach

Last year

First page Previous page 17 18 192021 22 23 Next page Last page